Product Code: PHA0442
The global anti-infective agents market is estimated to have reached $109bn in 2018 and is expected to grow at a CAGR of 4.2% during the forecast period. In 2018, the hospital pharmacy segment dominated the distribution channel of the anti-infective agents market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 154-page report you will receive 127 charts - all unavailable elsewhere.
The 154-page report provides clear detailed insight into the anti-infective agents market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
- Global Anti-infective Agents Market forecasts from 2019-2029
- Global Anti-infective Agents Market forecasts from 2019-2029 by Type :
- Antiviral infections
- Antibacterial infections : B-Lactams, Quinolones, Macrolides, Tetracycline, Aminoglycoside
- Antifungal infections : Azoles, Echinocandins, Polyenes
- Global Anti-infective Agents Market forecasts from 2019-2029 by Indication :
- Hepatitis Virus Infection
- HIV Infection
- Pneumonia
- Aspergillosis
- Methicillin-resistant Staphylococcus Aureus (MRSA)
- Dermatophytosis
- Tuberculosis
- Respiratory Virus Infection
- Sepsis
- Global Anti-infective Agents Market forecasts from 2019-2029 by Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Online Sales
- Global Anti-infective Agents Market forecasts from 2019-2029 by regional and national market :
- North America (US, Canada)
- Europe (Germany, UK, France, Rest of Europe)
- Asia Pacific (Japan, China, India, Rest of APAC)
- RoW (Latin America, Middle East and Africa)
- Profiles of the selected leading companies:
- Abbott Laboratories
- Bristol-Myers Squibb
- GlaxoSmithKline (GSK)
- Merck & Co.
- Novartis AG
- Sanofi SA
- Pfizer
- Anti-infective agents R&D Pipeline
- Key Questions Answered by this Report:
- How is the Anti-infective Agents market evolving?
- What is driving and restraining the Anti-infective Agents market dynamics?
- How will each of the submarkets grow over the forecast period and how much revenue will these submarkets account for in 2029?
- How will the market shares for each of the Anti-infective Agents submarkets develop from 2019 to 2029?
- What will be the main driver for the overall market from 2019-2029?
- How will political and regulatory factors influence the regional markets and submarkets?
- How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
- Who are the leading players and what are their prospects over the forecast period?
- How will the industry sector evolve during the period between 2019 and 2029?
Visiongain's study is intended for anyone requiring commercial analyses for the global anti-infective agents Market. You find data, trends and predictions.
Table of Contents
1. Report Overview
- 1.1 Global Anti-infective agents market Overview
- 1.2 Global Anti-infective agents market Segmentation
- 1.3 Overview of Findings
- 1.4 Structure of the Report
- 1.5 Why You Should Read This Report
- 1.6 Key Questions Answered by This Analytical Report
- 1.7 Who is This Report For?
- 1.8 Methodology
- 1.9 Frequently Asked Questions (FAQ)
- 1.10 Associated Visiongain Reports
- 1.11 About Visiongain
2. Introduction to Anti-infectives
- 2.1 What Are Anti-infectives?
- 2.2 Characteristics of Anti-infective agents
- 2.3 Rare Disease Facts and Statistics
- 2.4 Common Infectious Diseases Worldwide
- 2.5 Types of Anti-infectives
- 2.5.1 Anti-bacterial Drugs
- 2.5.2 Anti-fungal drugs
- 2.5.3 Anti-viral drugs
3. Anti-infectives: World Market 2019-2029
- 3.1 Anti-infective agents market Overview, 2018
- 3.2 The World Anti-infective Agents market
- 3.3 World Anti-infective Agents market: Sales Forecast 2019-2029
- 3.4 Changing Market Shares by Region 2018-2029
4. Anti-infectives: Qualitative Analysis 2019-2029
- 4.1 Anti-infective Agents Market: Drivers 2019-2029
- 4.1.1 Increase in Prevalence of Infectious Diseases
- 4.1.2 High Investment in Anti-infective agents R&D
- 4.1.3 Growing Support of Government
- 4.2 Anti-infective agents market Restraints: 2019-2029
- 4.2.1 Challenges in Research and Development
- 4.2.2 Stringent Government Regulations
5. Anti-infective Agents Market by Indication, 2019-2029
- 5.1 Market Overview
- 5.2 Market Forecast 2019-2029
- 5.2.1 Hepatitis Virus Infection: Market Forecast, 2019-2029
- 5.2.2 HIV Infection: Market Forecast, 2019-2029
- 5.2.3 Pneumonia: Market Forecast, 2019-2029
- 5.2.4 Aspergillosis: Market Forecast, 2019-2029
- 5.2.5 Methicillin-resistant Staphylococcus Aureus (MRSA): Market Forecast, 2019-2029
- 5.2.6 Dermatophytosis: Market Forecast, 2019-2029
- 5.2.7 Tuberculosis: Market Forecast, 2019-2029
- 5.2.8 Respiratory Virus Infection: Market Forecast, 2019-2029
- 5.2.9 Sepsis: Market Forecast, 2019-2029
6. Anti-infective Agents Market by Type, 2019-2029
- 6.1 Market Overview
- 6.2 Market Forecast 2019-2029
- 6.3 Antiviral Infections Market
- 6.4 Antibacterial Infection Market
- 6.4.1 B-Lactams Market
- 6.4.2 Quinolones Market
- 6.4.3 Macrolides Market
- 6.4.4 Tetracycline Market
- 6.4.5 Aminoglycoside Market
- 6.5 Antifungal infection Market
- 6.5.1 Azoles Market
- 6.5.2 Echinocandins Market
- 6.5.3 Polyenes Market
7. Anti-infective Agents Market by Distribution Channel 2019-2029
- 7.1 Market Overview
- 7.2 Market Forecast 2019-2029
- 7.3 Hospital Pharmacies
- 7.4 Retail Pharmacies
- 7.5 Online Sales
8. Anti-infective Agents market - Pipeline Analysis 2019-2029
- 8.1 Antibacterials in Development
- 8.2 Antifungals in Development
- 8.3 Antivirals in development
9. Leading National Markets 2019-2029
- 9.1 Geographical Breakdown of the World Anti-infective Agents market
- 9.2 Global Anti-infective Agents market: Regional Forecast 2019-2029
- 9.3 How Will Regional Market Shares Change to 2029?
- 9.4 North America Anti-infective Agents market, 2019-2029
- 9.4.1 US Anti-infective Agents Market Forecast 2019-2029
- 9.4.2 Canada Anti-infective Agents Market Forecast 2019-2029
- 9.5 Europe Anti-infective Agents market, 2019-2029
- 9.5.1 Europe Anti-infective agents market Forecast 2019-2029
- 9.5.2 Germany Anti-infective Agents Market Forecast 2019-2029
- 9.5.3 UK Anti-infective Agents Market Forecast 2019-2029
- 9.5.4 French Anti-infective Agents Market Forecast 2019-2029
- 9.5.5 Rest of Europe Anti-infective Agents Market Forecast 2019-2029
- 9.6 Asia-Pacific Anti-infective Agents Market 2019-2029
- 9.6.1 Japanese Anti-infective Agents Market Forecast 2019-2029
- 9.6.2 Chinese Anti-infective Agents Market 2019-2029
- 9.6.3 Indian Anti-infective Agents Market 2019-2029
- 9.6.4 Rest of APAC Anti-infective Agents Market Forecast 2019-2029
- 9.7 RoW Anti-infective Agents Market 2019-2029
- 9.7.1 Latin American Anti-infective Agents Market Forecast 2019-2029
- 9.7.2 MEA Anti-infective Agents Market 2019-2029
10. Anti-infective Agents Market: Qualitative Analysis, 2019-2029
- 10.1 Anti-infective Agents Market: SWOT Analysis, 2019-2029
- 10.1.1 Strengths
- 10.1.1.1 Promising Anti-infective Drugs R&D Pipeline
- 10.1.1.2 Increase in incidence of infectious diseases and healthcare awareness
- 10.1.2 Weaknesses
- 10.1.3 High Research and Development Cost
- 10.1.4 Opportunities
- 10.1.5 Demand from Emerging Market Continues
- 10.1.6 Increase in Government Support
- 10.1.7 Threats
- 10.1.8 Uncertainty of R&D Results
- 10.1.9 Barriers to Market Entry
- 10.2 Anti-infective Agents Market: Porters Five Forces Analysis, 2019-2029
- 10.2.1 Bargaining Power of Supplier: Moderate
- 10.2.2 Bargaining Power of Buyer: Medium
- 10.2.3 Competitive Rivalry: Medium
- 10.2.4 The Threat of New Entrants: Low
- 10.2.5 Threat of Substitutes: Medium
11. Company Profiles
- 11.1 Pfizer
- 11.1.1 Financial Overview
- 11.1.2 Recent Developments
- 11.2 Bristol-Myers Squibb Company
- 11.2.1 Financial Overview
- 11.2.2 Recent Developments
- 11.3 Merck & Co., Inc.
- 11.3.1 Financial Overview
- 11.3.2 Recent Developments
- 11.4 Novartis AG
- 11.4.1 Financial Overview
- 11.5 Sanofi S.A.
- 11.5.1 Financial Overview
- 11.5.2 Recent Developments
- 11.6 GlaxoSmithKline Inc
- 11.6.1 Company Overview
- 11.6.2 Operating Segments
- 11.6.3 Financial Highlights
- 11.6.4 Recent Developments
- 11.7 Abbott Laboratories
- 11.7.1 Sales and Recent Performance Analysis
12. Conclusion
Appendices
- Associated Visiongain Reports
- Visiongain Report Sales Order Form
- About Visiongain
- Report Evaluation Form